Drug and Alcohol Dependence

Article	Citations
Letter to the Editor regarding: Is implementation of ASAM-based addiction treatment assessments associated with improved 30-day retention and substance use? (By Mark et al., 2021)	302
A novel long-acting formulation of oral buprenorphine/naloxone produces prolonged decreases in fentanyl self-administration by rhesus monkeys	245
Development and validation of the Schedule for the Assessment of Insight in Alcohol Dependence (SAI-AD): Dimensions and correlates of insight in alcohol use disorder	140
Editorial Board	126
Editorial Board	102
Access to methadone clinics and opioid overdose deaths in Georgia: A geospatial analysis	99
EFFECTS OF SOCIAL DEFEAT STRESS EXPOSURE ON SPATIAL MEMORY PERFORMANCE IN SOCIALLY MONOGAMOUS MALE PRAIRIE VOLES	97
EXPLORING ASSOCIATIONS BETWEEN TRADITIONAL GENDER NORMS AND PRE-IMMIGRATION SEXUAL RISK BEHAVIORS AMONG MALE & FEMALE RECENT LATINO/A IMMIGRANTS	71
SEX AND GENOTYPE DEPENDENT DRUG-INDUCED DOPAMINE RELEASE IN ADOLESCENT CHRNA6 3’-UTR RATS	70
Neighborhood disadvantage and prescription drug misuse in low-income urban mothers	67
Corrigendum to “Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study” [Drug and Alcohol Dependence 219 (2021) 108435]	63
A randomized pilot trial of two forms of behavioral economics intervention to improve engagement in buprenorphine-naloxone treatment among patients with opioid use disorder	61
Correlates of solitary alcohol and cannabis use among American Indian adolescents	59
Ethnic density effect on alcohol-related hospitalizations among Chinese enclaves and ethnoburbs in California, 2007–2011	56
The moderating role of resilience in the relationship between experiences of COVID-19 response-related discrimination and disinformation among people who inject drugs	54
Corrigendum to “Longitudinal latent class analysis of tobacco use and correlates among young adults over a 10-year period” [Drug Alcohol Depend. 236 (2022) 109474]	54
Impact of the Russian invasion on opioid agonist therapy programs in Ukraine: A qualitative study	54
Socioeconomic inequalities in alcohol consumption in Argentina: Comparative analysis from 2009, 2013, and 2018	52
Validation of a single question for the assessment of past three-month alcohol consumption among adolescents	51
The effects of combination levodopa-ropinirole on cognitive improvement and treatment outcome in individuals with cocaine use disorder: A bayesian mediation analysis	50
Comparing Racial and Ethnic Differences on Access to Wellness Services for People in Substance Use Treatment	49
Use of laboratory data for illicit drug use surveillance and identification of socioeconomic risk factors	49
Receiving Medications for Opioid Use Disorder in Maryland Correctional Facilities and at a Community-Based Low-Threshold Buprenorphine Program Post-Release: Patient and Staff Perspectives	48
UTILIZING INNOVATIVE APPROACHES TO ENHANCE THE FULL POTENTIAL OF SUBSTANCE USE DATA TO BENEFIT MINORITIZED POPULATIONS	47
Sex Differences in Contextual Cocaine Seeking Behavior are Driven by Noradrenergic Signaling to the Dorsal Hippocampus	47

Misuse Potential of Medicinal Ketamine in Real-World Clinical Contexts, Part 1: Patients With At-Home Prescribed Ketamine	46
Guanfacine Reduces Drug Craving, Stress and Increases the Number of Abstinence Days in Women With Polysubstance Use Disorder (PSUD): A Pilot 2-Site Clinical Study	45
Risky Polysubstance Use Among People who Use Opioids in a Community-Based Study	45
Clinical Translation of the HR/LR Model of SUD Propensity	45
Evaluation of Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use via Ecological Momentary Assessments	43
BRIDGING THE GAP: PRACTICAL AND ETHICAL CONSIDERATIONS ON THE UTILITY OF ARTIFICIAL INTELLIGENCE IN SUBSTANCE USE DISORDERS	43
Provider Perspectives on Child Protective Services Reporting for Perinatal Patients With Opioid Use Disorder	42
Beyond Rest: Unraveling the Nexus of Sleep Deficiency, Environment, Control, and their Influence on Opioid Use Disorder Treatment Outcomes	40
Adolescent Gender Diversity and Substance Use Exposure: A Mediating Role of Peer Victimization	40
Characterizing Substance Use Disorder on Reddit Through Network Analysis and Transitions of Use Between Opioids, Cannabis, and Other Drugs	39
The Association between Poly-victimization and Opioid Misuse Among Justice-Involved Adolescents	39
The Effects of Acupuncture Stimulation at Shenmen (HT7) on Brain Stimulation Reward in Rats	39
Chronic Oral Dosing of Cannabidiol (CBD) With and Without low Doses of Delta-9-Tetrahydrocannabinol (Δ-9-THC)	38
A Comparative Study of Behavioral Effects of Novel Designer Drugs in Male Rodents	38
Racial and Ethnic Disparities in Telehealth and Emergency Department Use Among Women With Substance Use Disorder during the COVID-19 Pandemic	38
Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs	38
Comparative Effectiveness of Intranasal Naloxone and Nalmefene in a Translational Model Assessing Reversal of Cardiac Arrest Induced by Synthetic Opioid Overdose	37
Factors Associated With Self-Directed Discharge Among Hospitalized Individuals With a Substance Use Disorder	37
Denial of Prescription Pain Medication Among People Who Use Drugs in Vancouver, Canada	37
Determination of Yohimbine's Reinforcing Actions in Male and Female Rats	37
Risk of COVID-19 Hospitalization and Death in Patients on Chronic Opioid Therapy and With Opioid Use Disorder	36
Pharmacology of Newer Synthetic Cannabinoids at the CB1 Receptor	36
Nalfurafine is Aversive at Analgesic Doses - Non-Clinical Evidence to Indicate It is Not an Atypical Kappa Opioid Receptor Agonist	36
Pilot randomized trial of cognitive-behavioral treatment plus contingency management for quitting smoking and weight gain prevention among smokers with overweight or obesity	35
Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis	35
Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–17	35
Worsening trends in the frequency of methamphetamine and other stimulant use between treatment admission and discharge	35
Assessment of the Publication Trends of the Harm Reduction Studies over 40 Years	35
Types of criminal legal system exposure and polysubstance use: Prevalence and correlates among U.S. adults in the National Survey on Drug Use and Health, 2015–2019	34
Avoidance of Racial Trauma Exposure and Concurrent Substance Use Among Racial/Ethnic Minoritized Young Adults	34
Health care provider decision-making around prenatal substance use reporting	34
A Pilot Study of 16-Week Intensive Outpatient Treatment for Gay and Bisexual Men With Methamphetamine Use Disorder in Taiwan	34
XYLAZINE: AN ADULTERANT DRUG OF CONCERN	33
TERPENE AND CANNABINOID PROFILE PREFERENCES AND CANNABIS USE PRACTICES IN MEDICAL CANNABIS PATIENTS WHO USE CANNABIS FOR PAIN AND ANXIETY	33
More Stress Than You Know: A Qualitative Study of Client Experiences Navigating MOUD Treatment	32
How Common is Fentanyl Contamination of Methamphetamine? Attitudes, Self-Reported Exposures, and Toxicology Data From Persons who Use Methamphetamine	32
Preferences for Abstinence-Based Recovery and Public Stigma Toward Substance Use	32
Ethical and Methodological Challenges in Studying Discontinuation of Medications for Opioid Use Disorder	31
Perceived Stigma on the Emotional Wellbeing Among Latinx With Substance Use Disorders: The Mediated Roles of Self-Stigma and Self-Efficacy	31
A Novel 3mg Naloxone Nasal Spray for the Over-the-Counter Market	31
A Novel Hand-Held Personalized Dual Biometrically Controlled Device for At-Home Dispensation of Methadone	31
Treatment Engagement, Cigarette Smoking, and Quit Attempts one Month After a Randomized Controlled Trial of E-Cigarette Reduction Among Dual Users	31
Post-Stress Late Positive Potential Prospectively Predicts Cannabis Use Disorder Severity in Cannabis Using Women	31
Cannabis use and subjective response to alcohol in the human laboratory	30
Relationship perceptions and conflict behavior among cannabis users	30
Effects of access condition on substance use disorder-like phenotypes in male and female rats self-administering MDPV or cocaine	30
SYMPOSIUM: 10 YEARS GONE: REMEMBERING BILL WOOLVERTON THROUGH HIS IMPACT ON OUR CURRENT RESEARCH PROGRAMS	30
Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization study	29
Substance-induced mental disorders and discontinuation of medication for opioid use disorder	29
Why do Americans use marijuana?	29

Screening in Trauma for Opioid Misuse Prevention (STOMP): Results from a prospective cohort of victims of traumatic injury	29
The use of Australian SMART Recovery groups by people who use methamphetamine: Analysis of routinely-collected nationwide data	29
Prescription opioid use and employment: A nationwide Finnish register study	29
The opioid epidemic in rural communities: Can telehealth increase access to medications for opioid use disorder and offset barriers to care?	28
Does substance use disorder treatment completion reduce the risk of treatment readmission in Chile?	28
Social addiction or nicotine addiction? The effect of smoking social motivation on inhibitory control under smoking social cues: Evidence from ERPs	28
Generational shifts in attitudes and beliefs about alcohol: An age-period-cohort approach	28
Drug use and needle sharing among adolescents and young adults in Nigeria: A cross-sectional secondary analysis of data from a multi-site clinical trial	28
Long-term opioid therapy tapering: Trends from 2014 to 2018 in a Midwestern State	28
Reduced neural functional connectivity during working memory performance in methamphetamine use disorder	27
CULTURALLY RESPONSIVE TRAINING TO PRACTITIONERS: REDUCING MENTAL HEALTH DISPARITIES AMONG HISPANIC AND LATINOS	27
Disclosure processes as predictors of relationship outcomes among people in recovery from opioid use disorder: A longitudinal analysis	27
Associations between right inferior frontal gyrus morphometry and inhibitory control in individuals with nicotine dependence	27
The centrality of craving in network analysis of five substance use disorders	27
Effects of very low nicotine cigarettes, e-cigarettes, and nicotine patches on daily own-cigarette abstinence in a randomized controlled switching trial	27
Trends in homelessness and injection practices among young urban and suburban people who inject drugs: 1997-2017	27
Exploring the relationship between sleep disturbances and cannabis use outcomes among Hispanic/Latino young adults	27
VAGINAL INSTABILITY AND DYSBIOSIS IS PREVALENT AMONG HISPANIC WOMEN LIVING IN PUERTO RICO REGARDLESS OF BODY MASS INDEX	26
CHARACTERIZING MULTISYSTEM STIGMA: EXAMINING ITS ADVERSE IMPACT ON MOTHERS' ENGAGEMENT AND RETENTION IN RESIDENTIAL SUD TREATMENT	26
Characterizing Empirically-Derived Sub-Groups of Latinx PWID Living Along the U.S.-Mexico Border for HIV and HCV Prevention	26
Methodological considerations when assessing symptoms of nicotine dependence by cigarette and e-cigarette use behavior and brand	26
NIAAA Update Presented by George Koob, Director of the National Institute on Alcohol Abuse and Alcoholism	26
Dose by design: How limits on nicotine flux and puff duration affect the abuse liability of electronic nicotine delivery systems	26
Rates of Medication Prescription, Mental Health Disorder, and HCV Diagnoses Among Patients With Comorbid Alcohol and Opioid Use Disorder in Rural Primary Care Clinics	26
THE FAMILIAR TASTE OF POISON: A QUALITATIVE STUDY OF MULTI-LEVEL MOTIVATIONS FOR STIMULANT USE IN SEXUAL MINORITY MEN LIVING IN SOUTH FLORIDA	25
SUVOREXANT, AN FDA-APPROVED DUAL OREXIN RECEPTOR ANTAGONIST, EFFECTIVELY REDUCES OXYCODONE SELF-ADMINISTRATION AND CONDITIONED REINSTATEMENT IN MALE AND FEMALE RATS	25
Factors Associated With Risk for Cannabis Use Disorder Among Adults Using Medical Marijuana in Florida	25
Substance Co-Exposure Among Women With Opioid Use During Pregnancy	25
GABAPENTIN UTILIZATION AMONG BUPRENORPHINE-PRESCRIBED INDIVIDUALS WITH OPIOID USE DISORDER AND ASSOCIATED RISK OF OVERDOSE	25
DEPRESSION SCREENING AMONG PERINATAL PATIENTS WITH AND WITHOUT SUBSTANCE USE DISORDERS FOLLOWING IMPLEMENTATION OF A COLLABORATIVE CARE PROGRAM	25
Syndemic Profiles and Opioid-Related Mortality Among People Initiating Chronic Episodes of Prescription Opioid Use in BC, Canada	25
Perceptions of Racism’s Impact on Drug Use Among African Americans Using Opioids	25
RECENT INCARCERATION, SUBSTANCE USE, OVERDOSE, AND TREATMENT AMONG RURAL PEOPLE WHO USE DRUGS	25
Domestic Cannabis Cultivation: Results of the Georgian (country) Sample of the Transnational Online Survey of Cannabis Growers	25
Brandeis/Harvard Spire Center: SUD Systems Performance Improvement Research and Engagement	25
Common and Distinct Associations Between Baseline Impulsivity and Longitudinal Development of Positive and Negative Alcohol Expectancies in the Adolescent Brain Cognitive Development (ABCD) Cohort	24
Disparities in the Hepatitis C Virus Cascade of Care Among Reproductive Age Women With Opioid Use Disorder	24
Performance of a Brief Substance Use Symptom Checklist (SUSC) for Identifying Substance Use Disorder Among Primary Care Patients With or at Elevated Risk for Opioid Use Disorder	24
Psychosocial and Drug Use Characteristics in Persons With Opioid Use Disorder and Chronic Pain	24
Characterization of Peer Support Services for Substance Use Disorders in 11 U.S. Emergency Departments in 2020: Findings From a Nida Clinical Trials Network Study Site Selection Process	24
Primary Form of Cannabis Use and Recent Negative Affect Symptoms	24
Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial	24
Sex Differences in the Prospective Association of Intra-Individual Reaction Time Variability in Stroop and Hazardous Cannabis Use at Six Months	24
Self-Perception of Smoking Status and Co-Use of Cannabis and Narcotic Pain Medication	23
Optimizing Recovery Funding: Barriers to Acquiring Funding Among Organizations in the Ecosystem of Recovery	23
Alcohol use in firefighters: A network model of behaviors and transdiagnostic risk	23
Stakeholder preferences for supervised consumption site design, staff, and ancillary services: A scoping review of feasibility studies	23
Behavioral and Psychosocial Predictors of Cannabis Use Among Youth During the COVID-19 Pandemic	23
Treatment Outcomes From Computerized CBT for Substance Use Disorders Among People With Criminal Justice Involvement	23
Protecting historically marginalized groups or targeted marketing? A computational analysis of individuals engaging with public and protected cigar-branded tweets	23
Cannabis Use Effects on Reaction Time in Daily Versus Occasional Users	23
Outcomes of the Community-Based Medication-First Program for Opioid Use Disorder: A Multisite Hybrid Implementation Study	23
MEDIA FORUM	23
Secondhand electronic cigarette aerosol in vehicles impacts indoor air quality	23
APP-BASED CONTINGENCY MANAGEMENT TO REDUCE HEAVY DRINKING DAYS AMONG SMOKERS RECEIVING VARENICLINE: FINDINGS FROM A WITHIN-SUBJECT A-B-A DESIGN TRIAL	22
Examining the effect of prescription drug monitoring program integration and mandatory use policies on the distribution of methadone and buprenorphine for opioid use disorder, United States, 2009–2021	22
Naloxone Stigma Among People With Substance Use Disorder: Characteristics and Associations With Stigma toward Medication for Opioid Use Disorder (MOUD)	22
Modes of Cannabis Administration and Their Associations With Binge Drinking Among 12th Grade Students in the United States: A Cross-Sectional Analysis from 2018-2021	22
Oral Oxycodone Self Administration in Rats With a History of Responding under a Multiple Schedule for Ethanol and Food or Oxycodone and Food	22
Assessing inequities in buprenorphine treatment across the care cascade	22
Barriers and Facilitators to Injectable Opioid Agonist Treatment Engagement: A Qualitative Study of Patient Experiences in Vancouver, Canada	22
Editorial Board	22
Pregnancy Rates Among Women Treated With Medication for Opioid Use Disorder	22
How has the brain disease model of addiction contributed to tobacco control?	22
Methodology for Single- vs Polydrug Classification of Poisoning Deaths	22
Perceptions of the Combining HIV Services and Microenterprise for Sustainable Recovery (CHIMES) Intervention for Sober House Residents in Tanzania: A Qualitative Study	22
The Association Between Sleep Health and Multiple Tobacco Product Use Among Low-Income Smokers	21
SUBSTANCE USE DISORDERS AND ASSOCIATED MEDICAL CONSEQUENCES: IMPLICATIONS FOR PREVENTION AND TREATMENT	21
Why Do Medical Cannabis Patients use Illicit Medicinal Cannabis in the State of Utah?	21
Qualitative Exploration of Opioid Overdose Response Steps Among Women Who Use Drugs on the Rural Eastern Shore of Maryland	21
Pregnenolone Effects on Cocaine Use in Individuals with Cocaine Use Disorder	21
Differences in Methamphetamine Use and Self-Reported Impact by Gender and Sexual Orientation in a Multisite U.s. Cohort of People with Hiv in Care	21
Sex Differences in Lifetime Non-Medical Prescription Opioid and Cannabis Use Among Older Adults in the All of Us Research Program	21
Causally Linkage of Adolescent Behavioral Anomalies to Prenatal Opioid Exposure	21
Associations Between Interoceptive Control of Avoidance and Patterns of Morphine Self-Administration	21
Characterizing Online Questions and Answers about Cannabis Use and Pregnancy: Data Mining and Content Analysis on the Social Media Platform Quora	21
Beyond Euphoria: Transcriptomic Investigation in the rat Brain Under the Administration of Fentanyl Combined With Xylazine	21
Mental Health Care Barriers for Women Involved in the Criminal Legal System With Substance Use Disorders: A Qualitative Study	21
Real-World Abuse-Related Data for a Schedule Ii Serdexmethylphenidate and Dexmethylphenidate (SDX/d-MPH) Drug Product Suggests Low Rates of Abuse	21
Provision of Recovery Support Services in Opioid Use Disorder (OUD) Treatment Settings: A Secondary Data Analysis of the National Survey of Substance Abuse Treatment Services (N-SSATS) Data	21

Impact of the Sudden Closure of Mexico’s Only Methadone Manufacturing Plant on the Mental, Financial and Social Health of Patients With Opioid Use Disorder (OUD) in Tijuana, Mexico	21
A Qualitative Analysis of Individual, Relationship, and Community Factors Influencing Non-Initiation of Medications for Opioid Use Disorder During Incarceration	20
Racialized Differences in the Prevalence of Drug Use Disorder Among Transgender Veterans	20
“I Feel like People Would Look at Me like I’m Dirty or like I’m a Thief:” a Qualitative Exploration of Internal Experiences that Influence Recovery Among Adults at Risk of Opioid-Related Overdose	20
Experiential Smoking Urges and Nicotine Withdrawal Reduction Among People Under Community Corrections Supervision Enrolled in In Vivo NRT Counseling	20
Perceptions of Cannabis and its Associations With Mental Health Amongst Budtenders in Southern Ontario	20
Liver Disease Among People who Inject drugs: A Prospective Longitudinal Cohort Study Linked to Administrative Hospital Data	20
Within-Subject Evaluation of Technology-Assisted Buprenorphine Treatment	20
“Icy” Flavor Components in E-cigarette Images: Influence on Liking and Intention to Use Among Youth Who are Susceptible to E-cigarette Use	20
Conducting Community-Based Research on Substance Use in Rural Canada: Ethical and Methodological Considerations for Future Research	20
In Vivo Imaging Evidence of a Neuroinflammatory Phenotype Among Patients With Opioid Use Disorder	19
Editorial Board	19
College-based social and situational predictors of real-time prescription drug misuse in daily life	19
Tobacco use is associated with low peripheral beta-arrestin 1 levels in major depression: A preliminary report	19
Maryland Opioid Overdose Deaths From 2018 to 2021: Occupational Pattern and Its Sociodemographic Variations	19
Depression Outcomes Among Women Participating in Worth Transitions	19
Trends in overdose deaths involving gabapentinoids and Z-drugs in the United States	19
State marijuana policies and vaping associated lung injuries in the US	19
“I still partly think this is bullshit”: A qualitative analysis of cannabinoid hyperemesis syndrome perceptions among people with chronic cannabis use and cyclic vomiting	19
Pharmacist Involvement in Motivational Interviewing Intervention for Patients with Prescription Opioid Misuse Behaviors	19
Editorial Board	19
Who Gets Treatment And Who Gets Criminalized Racialized Associations Between Cannabis Arrests And Criminal Legal System Referrals To Cannabis Treatment, 1992-2019	19
Impact of reduced nicotine content on behavioral economic measures of cigarette reinforcement in adolescents who smoke cigarettes	19
Assessment of substance exposures in nail clipping samples: A systematic review	19
Adolescent depression symptoms and e-cigarette progression	18
Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system	18
Prospective association between screen use modalities and substance use experimentation in early adolescents	18
A Randomized Controlled Six-Way Crossover Study to Characterize the Nicotine Pharmacokinetics of a Novel Oral Nicotine Pouch Product	18
Prevalence and socio-structural determinants of tobacco exposure in young women: Data from the Healthy Trajectories Initiative (HeLTI) study in urban Soweto, South Africa	18
An investigation of multimodal predictors of adolescent alcohol initiation	18
Violence, policing, and systemic racism as structural barriers to substance use treatment amongst women sex workers who use drugs: Findings of a community-based cohort in Vancouver, Canada (2010–2019)	18
Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns	18
Modeling cue-exposure therapy for alcohol use disorder in rhesus monkeys: Effects of putative cognitive enhancers	18
Trends in poisonings involving ketamine in the United States, 2019–2023	18
Deficits in consummatory reward relate to severity of cocaine use	18
Associations between cannabis use, opioid misuse and severe psychological distress in adolescents: A cross-sectional school-based study	18
Prenatal alcohol exposure and offspring subsequent alcohol use: A systematic review	18
School party culture as a driver of cocaine use among Norwegian adolescents: A cross-classified multilevel analysis	18
Latent profiles of impulsivity facets and associations with drinking behaviors	18
Different brain oxidative and neuroinflammation status in rats during prolonged abstinence depending on their ethanol relapse-like drinking behavior: Effects of ethanol reintroduction	18
Identifying biomarkers of drug use recurrence using wearable device technologies and phone applications	18
Structural indices of brain aging in methamphetamine use disorder	18
Group behavioral activation with and without a smartphone app in intensive outpatient treatment for substance use disorder: A three-arm randomized controlled trial	18
Legality of drug checking equipment in the United States: A systematic legal analysis	18
DIFFERENCES IN TOBACCO SMOKING AND ALCOHOL CONSUMPTION AMONG 57,757 WOMEN FROM EARLY TO LATE PREGNANCY: A STATE-REPRESENTATIVE STUDY IN QUEENSLAND, AUSTRALIA	17
Editorial Board	17
Significant toxicity following an increase in poisonings with designer benzodiazepines in the Netherlands between 2010 and 2020	17
Chronic health conditions, acute health events, and healthcare utilization among adults over age 50 in Hawai’i who use cannabis: A matched cohort study	17
The defining characteristic of substance use disorders	17
Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats	17
Editorial Board	17
Changes in Opioid Agonist Treatment Initiation Following Voluntary and Mandatory Prescription Drug Monitoring Program Implementation: A Time Series Analysis	17
Associations of sex-related steroid hormones and proteins with alcohol dependence: A United Kingdom Biobank study	17
Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency	17
Clustering of risk behaviors and classification performance in modeling adolescent risk: The example of the association between E-cigarette use and cigarette smoking	17
Intimate partner violence is related to future alcohol use among a nationwide sample of LGBTQIA+ people: Results from The PRIDE Study	17
Drug Decriminalization in the United States: Emerging Models, Implementation Experiences and Implications for Health and Racial Equity	16
Untargeted Umbilical Cord Testing to Detect Novel Psychoactive Substances	16
Exploring Long-Term Trajectories of Quality of Life for People who are Treated With Methadone	16
Positive Methamphetamine Urinalysis Result During Treatment Intake is Not Associated With Worst Treatment Outcomes Amongst Opioid Users Initiating Medication-Assisted Opioid Treatment in Rural Communi	16
CAREGIVING AND COPING: ALCOHOL USE DURING THE PANDEMIC IN NEW YORK CITY	16
Oud Treatment, Harm Reduction Service Engagement, and Sexually Transmitted Infection Risk Among Men and Women who Use Illicit Opioids in New York City	16
Small Business Program: Implementation of a Technological Solution to Support Treatment for Opioid Use Disorder in the Primary Care Setting	16
High Threshold Prescribing Practices Associated With Increased Termination of Care: Results From a Survey of Michigan Buprenorphine Prescribers	16
Perceptions of Overdose Response Hotlines Among a Sample of People in Treatment for Substance Use Disorder	16
Health Justice Coordination for Increased Access to Health and Social Services for People With Drug Use Disorders in Contact With the Criminal Justice System	16
Incentivized Collaborative Care to Disseminate Contingency Management via Buprenorphine Treatment	16
Trends of Prenatal Substance Exposure: A 10 Year Evaluation of Umbilical Cord Test Outcomes	16
Using Biomarker Ratios to Distinguish Between Exclusive and Dual Use of Cigarettes, Smokeless Tobacco, and e-Cigarettes	16
Emotion Dysregulation Fully Mediates the Relationship between Stress and Impulsivity in Inpatients With Co-Occurring Substance Use and Mental Health Disorders	16
WORKSHOP: NEW APPROACHES TO CULTURALLY APPROPRIATE TREATMENT AND RESEARCH	16
Trends in fatal and nonfatal overdose by race among people who inject drugs in Baltimore, Maryland from 1998 to 2019	15
Risk factors for COVID-19 among persons with substance use disorder (PWSUD) with hospital visits – United States, April 2020–December 2020	15
Editorial Board	15
A Survey of Chronic Pain Patients regarding Drug Use and Opinions on Brain Stimulation as Treatment	15
NEUROLOGICAL AND BEHAVIORAL CHANGES 6 MONTHS AFTER GASTRIC SLEEVE METABOLIC SURGERY	15
Do Dual Users Vape When Attempting to Quit Smoking? The Association Between E-Cigarette Use and Concurrent Cigarette Cessation-Related Outcomes in a Prospective Natural History Study	15
A Passive Addiction Recruitment Strategy Among HIV Patients in Alabama: An Opportunity for Equitable Research Participation	15
Older Adults in Opioid Use Disorder Treatment: A Systematic Review of Health Outcomes	15
Daily impulsivity is associated with alcohol use and problems via coping motives, but not enhancement motives	15
Access to Medications for Opioid Use Disorders: A Multi-Site Comparison of Qualitative Evidence With Stakeholders	15
Risky alcohol use among patients dispensed opioid medications: A clinical community pharmacy study	15
Lifetime and 30-Day Drug Use Associated With Higher by FTND Scores	15
Trajectories of Medical Use of Prescription Opioids and Longitudinal Associations With Substance Use Disorder Symptoms in Adulthood (Ages 35-60)	15
Mesocorticolimbic Activation is Associated With Abstinence From Cannabis in a Pilot Trial of Varenicline for Cannabis Use Disorder	15
Alcohol-Focused Treatment With Mindfulness-Oriented Recovery Enhancement Shows Additional Beneficial Effects on Craving for Other Drugs	15
Comparative Effectiveness of Telemedicine Versus In-Person Buprenorphine Prescribing for Rural and Urban Patients	15
Substance use disorders and disparities in hispanic and non-hispanic older adults	15
Negative affect and craving during abstinence from smoking are both linked to default mode network connectivity	15
Gender Differences in Smoking Dependence Motives	15
Open Board	15
Emerging Hot Spot Analyses for Rapid Actionable Data for Opioid Response in Kentucky (RADOR-KY)	15
Program Descriptions of the “Multi-Sector and Multi-Level Community-Driven Approaches to Remove Structural Racism and Overdose Deaths in Black Indianapolis Communities” (MACRO-B) Project	15
SBIR: RAE cHealth: Assessing the Usability and Acceptability of Digital Health Intervention to Support Peer Recovery-Based SUD Treatment	15
Effects of the Social Cold Pressor Task on Stress Reactivity and Alcohol Craving and Demand	15